Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non‑microdosing controls

Key Points

• Greater observed improvements in mood and mental health are noted in psilocybin microdosers.
• Participants in the microdosing group reported significant effects, improving mood for over 30 days.
• Observational analysis compared outcomes of microdosing interventions against non-microdosing controls.
• The findings highlight potential benefits of psilocybin microdosing for mental health but require further exploration.